HALO
Halozyme Therapeutics, Inc.
$77.54
+1.72 (+2.27%)
At close · Jul 16
Market Cap
$9.20B
Shares
118,613,000
Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Squeeze Score
78/100
Short interest 11.2% of shares — P91
Days to cover 6.3 — P88
Price vs VWAP +9.5% — P83
Short-volume trend +4.1% — P67
Short interest change +2.1% — P53
Worst FTD 0.02% of shares — P55
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
| 2026-06-30 | 13,226,223 | 12,948,289 | +277,934 | 6.27 |
| 2026-06-15 | 12,948,289 | 13,644,245 | -695,956 | 7.84 |
| 2026-05-29 | 13,644,245 | 13,389,887 | +254,358 | 8.12 |
| 2026-05-15 | 13,389,887 | 14,381,741 | -991,854 | 6.72 |
| 2026-04-30 | 14,381,741 | 14,257,845 | +123,896 | 10.22 |
| 2026-04-15 | 14,257,845 | 14,046,350 | +211,495 | 10.57 |
| 2026-03-31 | 14,046,350 | 13,701,015 | +345,335 | 9.41 |
| 2026-03-13 | 13,701,015 | 13,498,344 | +202,671 | 8.40 |
| 2026-02-27 | 13,498,344 | 13,795,570 | -297,226 | 6.14 |
| 2026-02-13 | 13,795,570 | 13,515,827 | +279,743 | 6.46 |
| 2026-01-30 | 13,515,827 | 13,593,503 | -77,676 | 9.07 |
| 2026-01-15 | 13,593,503 | 13,800,472 | -206,969 | 6.10 |
| 2025-12-31 | 13,800,472 | 12,500,858 | +1,299,614 | 9.89 |
| 2025-12-15 | 12,500,858 | 12,372,896 | +127,962 | 4.44 |
| 2025-11-28 | 12,372,896 | 12,479,411 | -106,515 | 6.06 |
| 2025-11-14 | 12,479,411 | 11,305,141 | +1,174,270 | 3.91 |
| 2025-10-31 | 11,305,141 | 11,510,110 | -204,969 | 7.65 |
| 2025-10-15 | 11,510,110 | 10,797,290 | +712,820 | 4.80 |
| 2025-09-30 | 10,797,290 | 11,779,854 | -982,564 | 4.89 |
| 2025-09-15 | 11,779,854 | 11,883,269 | -103,415 | 6.41 |
| 2025-08-29 | 11,883,269 | 10,571,710 | +1,311,559 | 5.74 |
| 2025-08-15 | 10,571,710 | 9,932,500 | +639,210 | 4.63 |
| 2025-07-31 | 9,932,500 | 9,602,474 | +330,026 | 7.95 |
Showing 1–23 of 23 settlements
Key facts
CIK
1159036
CUSIP
40637H109
13F (30d)
78 filings
73 filers
Visit website
Investor relations